NAD+ is produced by the salvage pathway in hypoxic TME, which is further converted to adenosine by CD38-expressing cells, thus further suppressing the immune response by recruitment of MDSCs, Tregs, tumor associated macrophages (TAMs) [38, 39]. This evidence concerns the gene CD38 and neoplasm.